LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about AffyImmune Therapeutics…

AffyImmune Therapeutics Tech Stack

AffyImmune Therapeutics uses 8 technology products and services including RSS, Microsoft 365, Veeva Vault, and more. Explore AffyImmune Therapeutics's tech stack below.

  • RSS
    Content Management System
  • Microsoft 365
    Email
  • Veeva Vault
    Enterprise Content Management
  • Google Fonts API
    Font Scripts
  • Google Maps
    Maps
  • Lua
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics

Media & News

AffyImmune Therapeutics's Email Address Formats

AffyImmune Therapeutics uses at least 1 format(s):
AffyImmune Therapeutics Email FormatsExamplePercentage
FLast@affyimmune.comJDoe@affyimmune.com
46%
LastF@affyimmune.comDoeJ@affyimmune.com
7%
First-Last@affyimmune.comJohn-Doe@affyimmune.com
1%
FLast@affyimmune.comJDoe@affyimmune.com
46%

Frequently Asked Questions

Where is AffyImmune Therapeutics's headquarters located?

Minus sign iconPlus sign iconAffyImmune Therapeutics's main headquarters is located at 22 Strathmore Rd, Natick, Massachusetts 01760, US. The company has employees across 1 continents, including North America.

What is AffyImmune Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAffyImmune Therapeutics's official website is affyimmune.com and has social profiles on LinkedInCrunchbase.

What is AffyImmune Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAffyImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AffyImmune Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2025, AffyImmune Therapeutics has approximately 7 employees across 1 continents, including North America. Key team members include Chief Executive Officer: D. J.Co-Founder: G. S.Co-Founder: M. J.. Explore AffyImmune Therapeutics's employee directory with LeadIQ.

What industry does AffyImmune Therapeutics belong to?

Minus sign iconPlus sign iconAffyImmune Therapeutics operates in the Biotechnology Research industry.

What technology does AffyImmune Therapeutics use?

Minus sign iconPlus sign iconAffyImmune Therapeutics's tech stack includes RSSMicrosoft 365Veeva VaultGoogle Fonts APIGoogle MapsLuaGoogle Tag ManagerGoogle Analytics.

What is AffyImmune Therapeutics's email format?

Minus sign iconPlus sign iconAffyImmune Therapeutics's email format typically follows the pattern of FLast@affyimmune.com. Find more AffyImmune Therapeutics email formats with LeadIQ.

How much funding has AffyImmune Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2025, AffyImmune Therapeutics has raised $20M in funding. The last funding round occurred on Oct 07, 2021 for $20M.

When was AffyImmune Therapeutics founded?

Minus sign iconPlus sign iconAffyImmune Therapeutics was founded in 2016.

AffyImmune Therapeutics

Biotechnology ResearchUnited States2-10 Employees

Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy.

The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others.

Section iconCompany Overview

Headquarters
22 Strathmore Rd, Natick, Massachusetts 01760, US
Website
affyimmune.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    AffyImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2021 in the amount of $20M.

  • $1M$10M

    AffyImmune Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $20M

    AffyImmune Therapeutics has raised a total of $20M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2021 in the amount of $20M.

  • $1M$10M

    AffyImmune Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    D. J.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. S.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. J.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. H.
    Sr. Director, Clinical Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. B.
    Clinical Trial Manager
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. C.
    Principal Research Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. N.
    Senior Scientist, Process Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. P.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. N.
    Senior Scientist, Process Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. D.
    Cmc Engineer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.